OneMedNet Corp
For the period ended Dec 31, 2024. Filed Apr 15, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 15, 2025
ONMD$6.00+16.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(In thousands, except share and per share data)
| As of December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $172 | $47 |
| Investment in crypto assets – Bitcoin | 2,849 | - |
| Accounts receivable, net | 213 | 152 |
| Prepaid expenses and other current assets | 385 | 166 |
| Total current assets | 3,619 | 365 |
| Property and equipment, net | 108 | 99 |
| Total assets | $3,727 | $464 |
| Liabilities and stockholders’ deficit | ||
| Current liabilities: | ||
| Accounts payable & accrued expenses | $6,371 | $4,682 |
| Deferred revenues | 561 | 254 |
| Loan extensions | 2,992 | 2,992 |
| PIPE Notes | 1,734 | 1,637 |
| Yorkville Note | 1,718 | - |
| Deferred underwriter fee payable | 3,250 | 3,525 |
| Loan – related party | 2,319 | 465 |
| Other current liabilities | 283 | 283 |
| Total current liabilities | 19,228 | 13,838 |
| Other long-term liabilities | 449 | 68 |
| Total liabilities | 19,677 | 13,906 |
| Commitments and contingencies (Note 15) | - | - |
| Stockholders’ (deficit) equity: | ||
| Preferred Stock, par value $0.0001, 1,000,000 authorized at December 31, 2024 and 2023; no shares issued and outstanding at December 31, 2024 and 2023 | - | - |
| Common Stock, par value $0.0001, 100,000,000 shares authorized, 28,175,172 shares issued and 27,987,427 shares outstanding at December 31, 2024, and 23,572,232 shares issued and outstanding at December 31, 2023 | 2 | 2 |
| Additional paid-in-capital | 86,146 | 77,996 |
| Treasury stock, at cost, 187,745 and 0 shares at December 31, 2024 and 2023, respectively | (529) | - |
| Accumulated deficit | (101,569) | (91,440) |
| Total stockholders’ deficit | (15,950) | (13,442) |
| Total liabilities and stockholders’ deficit | $3,727 | $464 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.